Aortic stenosis and coronary artery disease: What do we know?What don't we know? A comprehensive review of the literature with proposed treatment algorithms

European Heart Journal

Volumn 35, Issue 31, 2014, Pages

  Paradis, Jean Michel ^a,b,c   Fried, Justin ^a   Nazif, Tamim ^a   Kirtane, Ajay ^a,b   Harjai, Kishore ^a   Khalique, Omar ^a   Grubb, Kendra ^a   George, Isaac ^a   Hahn, Rebecca ^a   Williams, Mathew ^a   Mathew, Martin B ^a,b   Kodali, Susheel ^a  

^a Department of Medicine   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic stenosis; Coronary artery disease; Percutaneous coronary intervention; Surgical aortic valve replacement; Transcatheter aortic valve replacement

Indexed keywords

ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADULT; AGED; ALGORITHM; AORTIC VALVE STENOSIS; BLOOD VESSEL CALCIFICATION; COMPLICATION; HEART VALVE REPLACEMENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; TIME TO TREATMENT; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; AORTIC VALVE STENOSIS; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; TIME-TO-TREATMENT; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84906688982     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu247     Document Type: Review

References (61)

1. Rapp AH, Hillis LD, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol 2001;87: 1216-1217
2. Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol 1988;62:117-120
3. Pibarot P, Dumesnil JG. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012;60:169-180
4. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, KitzmanDW, Otto CM.Clinical factors associated with calcific aortic valve disease.Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634
5. Iung B. Interface between valve disease and ischaemic heart disease. Heart 2000;84: 347-352
6. Adler Y, Vaturi M, Herz I, Iakobishvili Z, Toaf J, Fink N, Battler A, Sagie A. Nonobstructive aortic valve calcification: A window to significant coronary artery disease. Atherosclerosis 2002;161:193-197
7. Kvidal P, BergströmR,Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-756
8. Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol 1983;51:1005-1028
9. Thubrikar MJ, Deck JD, Aouad J, Chen JM. Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve. Atherosclerosis 1985;55:299-311
10. Garcia D, Camici PG, Durand L-G, Rajappan K, Gaillard E, Rimoldi OE, Pibarot P. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol 2009;106:113-121
11. Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, Camici PG. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002;105:470-476
12. Bartel T, Yang Y, Müller S,Wenzel RR, Baumgart D, Philipp T, Erbel R. Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography. J Am Coll Cardiol 2002;39:2012-2018
13. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, Maccarthy PA, Fearon WF. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-224
14. Stefanini GG, Stortecky S, Meier B, Windecker S,Wenaweser P. Severe aortic stenosis and coronary artery disease. EuroIntervention 2013;9:63-68
15. Stähli BE, MaierW, Corti R, Lüscher TF, Altwegg LA. Fractional flow reserve valuation in patients considered for transfemoral transcatheter aortic valve implantation: A case series. Cardiology 2012;123:234-239
16. Demirkol MO, Yaymaci B, Debeş H, Başaran Y, Turan F. Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis. Cardiology 2002;97: 37-42
17. Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 1997;95:892-898
18. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD. 2014 AHA/ACC Guideline for the Management of Patients With Valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;14:735-1097
19. Aranki S, Rizzo R, Couper G, Adams D, Collins J, Gildea J, Kinchla N, Cohn L. Aortic valve replacement in the elderly: Effect of gender and coronary artery disease on operative mortality. Circulation 1992;88:17-23
20. Dewey TM, Brown DL, Herbert MA, Culica D, Smith CR, Leon MB, Svensson LG, Tuzcu M, Webb JG, Cribier A, Mack MJ. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010;89:758-767
21. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L,Wenink A. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology, ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-2496.
22. Tjang YS, Korfer R, Grobbee DE. Predictors of mortality after aortic valve replacement. Eur J Cardiothorac Surg 2007;32:469-474
23. Hannan E, Wu C, Bennett E, Carlson R, Culliford A, Gold J, Higgins R, Smith C, Jones R. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007;83:921-929
24. Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, Johnston DR, Sabik JF III, Blackstone EH. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J AmColl Cardiol 2013;61:837-848
25. Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, Bajaj N, Joseph L, Patel NS, Aksoy O, Stewart WJ, GriffinBP, Kapadia SR. Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement. Circulation 2012;125:1005-1013
26. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn LH. Staged initial percutaneous coronary intervention followed by valve surgery ('hybrid approach') for patients with complex coronary and valve disease. J Am Coll Cardiol 2005;45:14-18
27. Brinster DR, Byrne M, Rogers CD, Baim DS, Simon DI, Couper GS, Cohn LH. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ('hybrid approach'). Am J Cardiol 2006;98:1501-1503
28. Santana O, Funk M, Zamora C, Escolar E, Lamas GA, Lamelas J. Staged percutaneous coronary intervention and minimally invasive valve surgery: Results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg 2012;144:634-639
29. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, LevangOW, Tornos P, Vanoverschelde J-L, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243
30. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607
31. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364:2187-2198
32. Gilard M, Eltchaninoff H, Iung B. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-1715
33. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Schiele R, Schneider S, Senges J. German Transcatheter Aortic Valve Interventions Registry Investigators. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol 2013;112:272-279
34. Thomas M, Schymik G,Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-433
35. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-2138
36. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308
37. Piazza N, Grube E, Gerckens U, Heijer den P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249
38. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55: 1080-1090
39. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, Buellesfeld L, Khattab AA, Meuli F, Roth N, Eberle B, Erdös G, Brinks H, Kalesan B, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol 2011;58:2151-2162
40. Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schächinger V, Mohr FW, Wimmer-Greinecker G. One-year interim follow-up results of the TRAVERCE trial: The initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2011;39:532-537
41. Petronio AS, De Carlo M, Bedogni F, Maisano F, Ettori F, Klugmann S, Poli A, Marzocchi A, Santoro G, Napodano M, Ussia GP, Giannini C, Brambilla N, Colombo A. 2-year results of CoreValve implantation through the subclavian access: A propensity-matched comparison with the femoral access. J Am Coll Cardiol 2012;60:502-507
42. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008;1:167-175
43. Lefèvre T, Kappetein AP,Wolner E, Nataf P, Thomas M, Schächinger V,De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P. Wimmer-Greinecker G, PARTNER EU Investigator Group. One year follow-up of the multicentre European PARTNER transcatheter heart valve study. Eur Heart J 2011;32: 148-157
44. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Détaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, Nataf P, Vahanian A. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009;54:303-311
45. Svensson LG,DeweyT, Kapadia S, Roselli EE, Stewart A, Williams M, AndersonWN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86:46-54
46. Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B, Cribier A, de Jaegere P, Fournial G, Kappetein A-P, Kovac J, Ludgate S, Maisano F, Moat N, Mohr FW, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Segesser von LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: A position statement fromthe European AssociationofCardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008;34:1-8.
47. Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011;57:1988-1999
48. Masson JB, Lee M, Boone RH, Ali Al A, Bugami Al S, Hamburger J, John Mancini GB, Ye J, Cheung A, Humphries KH,Wood D, Nietlispach F,Webb JG. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010;76:165-173
49. Gautier M, Pepin M, Himbert D, Ducrocq G, Lung B, Dilly MP, Attias D, Nataf P, Vahanian A. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 2011;7: 549-555
50. Ussia GP, Barbanti M, Colombo A, Tarantini G, Petronio AS, Ettori F, Ramondo A, Santoro G, Klugmann S, Bedogni F, Antoniucci D, Maisano F, Marzocchi A, Poli A, De Carlo M, Fiorina C, De Marco F, Napodano M, Violini R, Bortone AS, Tamburino C. on behalf of CoreValve Italian Registry Investigators. Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry. Int J Cardiol 2013;167:943-950
51. D'Ascenzo F, Conrotto F, Giordana F, Moretti C, D'Amico M, Salizzoni S, Omedè P, La Torre M, Thomas M, Khawaja Z, Hildick-Smith D, Ussia G, Barbanti M, Tamburino C,Webb J, Schnabel RB, Seiffert M, Wilde S, Treede H, Gasparetto V, Napodano M, Tarantini G, Presbitero P, Mennuni M, Rossi ML, Gasparini M, Biondi-Zoccai G, Lupo M, Rinaldi M, Gaita F, Marra S. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis of adjusted observational results. Int J Cardiol 2013;168:2528-2532
52. Van Mieghem NM, Van der Boon RM, Faqiri E, Diletti R, Schultz C, van Geuns R-J, SerruysPW, Kappetein A-P, van Domburg RT, de Jaegere PP. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv 2013;6:867-875
53. Gasparetto V, Fraccaro C, Tarantini G, Buja P, D'Onofrio A, Yzeiraj E, Pittarello D, Isabella G, Gerosa G, Iliceto S, Napodano M. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013;81:376-383
54. Abdel-Wahab M, Mostafa AE, Geist V, Stöcker B, Gordian K, Merten C, Richardt D, Toelg R, Richardt G. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol 2012; 109:581-586
55. Wendt D, Kahlert P, Lenze T, Neuhäuser M, Price V, Konorza T, Erbel R, Jakob H, Thielmann M. Management of high-risk patients with aortic stenosis and coronary artery disease. Ann Thorac Surg 2013;95:599-605
56. Wenaweser P, Pilgrim T, Guerios E, Stortecky S, Huber C, Khattab AA, Kadner A, Buellesfeld L, Gloekler S, Meier B, Carrel T, Windecker S. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011;7:541-548
57. Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T, Reichenspurner H, Treede H. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011;100:311-316
58. Geist V, Sherif MA, Khattab AA. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. Catheter Cardiovasc Interv 2009;73:61-67
59. Zajarias A, Eltchaninoff H, Cribier A. Successful coronary intervention after percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2007;69:522-524
60. Pasic M, Dreysse S, Unbehaun A, Buz S, Drews T, Klein C, D'Ancona G Hetzer R.Combinedelective percutaneous coronary interventionandtransapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012;14:463-468
61. Goel SS, Ige M, Tuzcu EM, Ellis SG, Stewart WJ, Svensson LG, LytleBW, Kapadia SR. Severe aortic stenosis and coronary artery disease-implications for management in the transcatheter aortic valve replacement era: A comprehensive review. J Am Coll Cardiol 2013;62:1-10